-
2
-
-
37849013375
-
Advanced lipid peroxidation end products in oxidative damage to proteins. Potential role in diseases and therapeutic prospects for the inhibitors
-
Negre-Salvayre A, Coatrieux C, Ingueneau C, Salvayre R. Advanced lipid peroxidation end products in oxidative damage to proteins. Potential role in diseases and therapeutic prospects for the inhibitors. Br J Pharmacol. 2008;153:6-20.
-
(2008)
Br J Pharmacol
, vol.153
, pp. 6-20
-
-
Negre-Salvayre, A.1
Coatrieux, C.2
Ingueneau, C.3
Salvayre, R.4
-
3
-
-
42149144227
-
-
Chou MY, Hartvigsen K, Hansen LF, Fogelstrand L, Shaw PX, Boullier A, Binder CJ, Witztum JL Oxidation-specific epitopes are important targets of innate immunity. J Intern Med. 2008263:479-488.
-
Chou MY, Hartvigsen K, Hansen LF, Fogelstrand L, Shaw PX, Boullier A, Binder CJ, Witztum JL Oxidation-specific epitopes are important targets of innate immunity. J Intern Med. 2008263:479-488.
-
-
-
-
4
-
-
0346100518
-
Scavenger receptors for oxidized and glycated proteins
-
Horiuchi S, Sakamoto Y, Sakai M. Scavenger receptors for oxidized and glycated proteins. Amino Acids. 2003;25:283-292.
-
(2003)
Amino Acids
, vol.25
, pp. 283-292
-
-
Horiuchi, S.1
Sakamoto, Y.2
Sakai, M.3
-
5
-
-
1542337781
-
Seeing strangers or announcing "danger": Galectin-3 in two models of innate immunity
-
Sato S, Nieminen J. Seeing strangers or announcing "danger": galectin-3 in two models of innate immunity. Glycoconj J. 2004;19:583-591.
-
(2004)
Glycoconj J
, vol.19
, pp. 583-591
-
-
Sato, S.1
Nieminen, J.2
-
6
-
-
0034813639
-
The role of galectin-3 in endocytosis of advanced glycation end products and modified low density lipoproteins
-
Zhu W, Sano H, Nagai R, Fukuhara K, Miyazaki A, Horiuchi S. The role of galectin-3 in endocytosis of advanced glycation end products and modified low density lipoproteins. Biochem Biophys Res Commun. 2001; 280:1183-1188.
-
(2001)
Biochem Biophys Res Commun
, vol.280
, pp. 1183-1188
-
-
Zhu, W.1
Sano, H.2
Nagai, R.3
Fukuhara, K.4
Miyazaki, A.5
Horiuchi, S.6
-
7
-
-
41049117932
-
Convergence and amplification of toll-like receptor (TLR) and receptor for advanced glycation end products (RAGE) signaling pathways via high mobility group B1 (HMGB1)
-
van Beijnum JR, Buurman WA, Griffioen AW. Convergence and amplification of toll-like receptor (TLR) and receptor for advanced glycation end products (RAGE) signaling pathways via high mobility group B1 (HMGB1). Angiogenesis. 2008;11:91-99.
-
(2008)
Angiogenesis
, vol.11
, pp. 91-99
-
-
van Beijnum, J.R.1
Buurman, W.A.2
Griffioen, A.W.3
-
8
-
-
37749053740
-
Toll-like receptors in atherosclerosis
-
Tobias PS, Curtiss LK. Toll-like receptors in atherosclerosis. Biochem Soc Trans. 2007;35:1453-1455.
-
(2007)
Biochem Soc Trans
, vol.35
, pp. 1453-1455
-
-
Tobias, P.S.1
Curtiss, L.K.2
-
9
-
-
38049063860
-
Receptor for advanced glycation endproducts and atherosclerosis: From basic mechanisms to clinical implications
-
Basta G. Receptor for advanced glycation endproducts and atherosclerosis: From basic mechanisms to clinical implications. Atherosclerosis. 2008;196:9-21.
-
(2008)
Atherosclerosis
, vol.196
, pp. 9-21
-
-
Basta, G.1
-
10
-
-
33746839790
-
Scavenger receptors in atherosclerosis: Beyond lipid uptake
-
Moore KJ, Freeman MW. Scavenger receptors in atherosclerosis: beyond lipid uptake. Arterioscler Thromb Vasc Biol. 2006;26:1702-1711.
-
(2006)
Arterioscler Thromb Vasc Biol
, vol.26
, pp. 1702-1711
-
-
Moore, K.J.1
Freeman, M.W.2
-
12
-
-
17944369113
-
Accelerated diabetic glomerulopathy in galectin-3/AGE-receptor-3 knockout mice
-
Pugliese G, Pricci F, Iacobini C, Leto G, Amadio L, Barsotti P, Frigeri L, Hsu DK, Vlassara H, Liu F-T, Di Mario U. Accelerated diabetic glomerulopathy in galectin-3/AGE-receptor-3 knockout mice. FASEB J. 2001;15:2471-2479.
-
(2001)
FASEB J
, vol.15
, pp. 2471-2479
-
-
Pugliese, G.1
Pricci, F.2
Iacobini, C.3
Leto, G.4
Amadio, L.5
Barsotti, P.6
Frigeri, L.7
Hsu, D.K.8
Vlassara, H.9
Liu, F.-T.10
Di Mario, U.11
-
13
-
-
9444289275
-
Galectin-3/AGE-receptor 3 knockout mice show accelerated AGE-induced glomerular injury. Evidence for a protective role of galectin-3 as an AGE-receptor
-
Iacobini C, Menini S, Oddi G, Ricci C, Amadio L, Pricci F, Olivieri A, Sorcini M, Di Mario U, Pesce C, Pugliese G. Galectin-3/AGE-receptor 3 knockout mice show accelerated AGE-induced glomerular injury. Evidence for a protective role of galectin-3 as an AGE-receptor. FASEB J. 2004;18:1773-1775.
-
(2004)
FASEB J
, vol.18
, pp. 1773-1775
-
-
Iacobini, C.1
Menini, S.2
Oddi, G.3
Ricci, C.4
Amadio, L.5
Pricci, F.6
Olivieri, A.7
Sorcini, M.8
Di Mario, U.9
Pesce, C.10
Pugliese, G.11
-
14
-
-
23944467090
-
Development of agedependent glomerular lesions in galectin-3/AGE-receptor-3 knockout and wild type mice
-
Iacobini C, Oddi G, Menini S, Amadio L, Ricci C, Barsotti P, Di Pippo C, Sorcini M, Pricci F, Pugliese F, Pugliese G. Development of agedependent glomerular lesions in galectin-3/AGE-receptor-3 knockout and wild type mice. Am J Physiol. 2005;289:F611-F621.
-
(2005)
Am J Physiol
, vol.289
-
-
Iacobini, C.1
Oddi, G.2
Menini, S.3
Amadio, L.4
Ricci, C.5
Barsotti, P.6
Di Pippo, C.7
Sorcini, M.8
Pricci, F.9
Pugliese, F.10
Pugliese, G.11
-
15
-
-
0032479459
-
Galectin-3 gene (LGALS3) expression in experimental atherosclerosis and cultured smooth muscle cells
-
Arar C, Gaudin JC, Capron L, Legrand A. Galectin-3 gene (LGALS3) expression in experimental atherosclerosis and cultured smooth muscle cells. FEBS Lett. 1998;430:307-311.
-
(1998)
FEBS Lett
, vol.430
, pp. 307-311
-
-
Arar, C.1
Gaudin, J.C.2
Capron, L.3
Legrand, A.4
-
16
-
-
0031898815
-
Galectin-3 expression in human atherosclerotic lesions
-
Nachtigal M, Al-Assaad Z, Mayer EP, Kim K, Monsigny M. Galectin-3 expression in human atherosclerotic lesions. Am J Pathol. 1998;152: 1199-1208.
-
(1998)
Am J Pathol
, vol.152
, pp. 1199-1208
-
-
Nachtigal, M.1
Al-Assaad, Z.2
Mayer, E.P.3
Kim, K.4
Monsigny, M.5
-
17
-
-
40749162391
-
Galectin-3 is an amplifier of inflammation in athero-sclerotic plaque progression through macrophage activation and monocyte chemoattraction
-
Papaspyridonos M, McNeill E, de Bono JP, Smith A, Burnand KG, Channon KM, Greaves DR. Galectin-3 is an amplifier of inflammation in athero-sclerotic plaque progression through macrophage activation and monocyte chemoattraction. Arterioscler Thromb Vasc Biol. 2008;28:433-440.
-
(2008)
Arterioscler Thromb Vasc Biol
, vol.28
, pp. 433-440
-
-
Papaspyridonos, M.1
McNeill, E.2
de Bono, J.P.3
Smith, A.4
Burnand, K.G.5
Channon, K.M.6
Greaves, D.R.7
-
18
-
-
0033870111
-
Targeted disruption of the galectin-3 gene results in attenuated peritoneal inflammatory responses
-
Hsu DK, Yang RY, Pan Z, Yu L, Salomon DR, Fung-Leung WP, Liu FT. Targeted disruption of the galectin-3 gene results in attenuated peritoneal inflammatory responses, Am J Pathol. 2000;156:1073-1083.
-
(2000)
Am J Pathol
, vol.156
, pp. 1073-1083
-
-
Hsu, D.K.1
Yang, R.Y.2
Pan, Z.3
Yu, L.4
Salomon, D.R.5
Fung-Leung, W.P.6
Liu, F.T.7
-
19
-
-
0022003324
-
Variation in susceptibility to atherosclerosis among inbred strains of mice
-
Paigen B, Morrow A, Brandon C, Mitchell D, Holmes P. Variation in susceptibility to atherosclerosis among inbred strains of mice. Atherosclerosis. 1985;57:65-73.
-
(1985)
Atherosclerosis
, vol.57
, pp. 65-73
-
-
Paigen, B.1
Morrow, A.2
Brandon, C.3
Mitchell, D.4
Holmes, P.5
-
20
-
-
0023634643
-
Quantitative assessment of atherosclerotic lesions in mice
-
Paigen B, Morrow A, Holmes PA, Mitchell D, Williams RA. Quantitative assessment of atherosclerotic lesions in mice. Atherosclerosis. 1987;68: 231-240.
-
(1987)
Atherosclerosis
, vol.68
, pp. 231-240
-
-
Paigen, B.1
Morrow, A.2
Holmes, P.A.3
Mitchell, D.4
Williams, R.A.5
-
21
-
-
33745571976
-
The immune response in atherosclerosis: A double-edged sword
-
Hansson GK, Libby P. The immune response in atherosclerosis: a double-edged sword. Nat Rev Immunol. 2006;6:508-519.
-
(2006)
Nat Rev Immunol
, vol.6
, pp. 508-519
-
-
Hansson, G.K.1
Libby, P.2
-
22
-
-
0033048632
-
Cytokine expression in advanced human atherosclerotic plaques: Dominance of proinflammatory (Th1) and macrophage-stimulating cytokines
-
Frostegård J, Ulfgren AK, Nyberg P, Hedin U, Swedenborg J, Andersson U, Hansson GK. Cytokine expression in advanced human atherosclerotic plaques: dominance of proinflammatory (Th1) and macrophage-stimulating cytokines. Atherosclerosis. 1999;145:33-43.
-
(1999)
Atherosclerosis
, vol.145
, pp. 33-43
-
-
Frostegård, J.1
Ulfgren, A.K.2
Nyberg, P.3
Hedin, U.4
Swedenborg, J.5
Andersson, U.6
Hansson, G.K.7
-
23
-
-
0032522995
-
Hypercholesterolemia is associated with a T helper (Th) 1/Th2 switch of the autoimmune response in atherosclerotic apoE-knockout mice
-
Zhou X, Paulsson G, Stemme S, Hansson GK. Hypercholesterolemia is associated with a T helper (Th) 1/Th2 switch of the autoimmune response in atherosclerotic apoE-knockout mice. J Clin Invest. 1998;101:1717-1725.
-
(1998)
J Clin Invest
, vol.101
, pp. 1717-1725
-
-
Zhou, X.1
Paulsson, G.2
Stemme, S.3
Hansson, G.K.4
-
24
-
-
47949094965
-
Integration of metabolism and inflammation by lipid-activated nuclear receptors
-
Bensinger SJ, Tontonoz P. Integration of metabolism and inflammation by lipid-activated nuclear receptors. Nature. 2008;454:470-477.
-
(2008)
Nature
, vol.454
, pp. 470-477
-
-
Bensinger, S.J.1
Tontonoz, P.2
-
26
-
-
22744454646
-
Vessel wall apoptosis and atherosclerotic plaque instability
-
Kavurma MM, Bhindi R, Lowe HC, Chesterman C, Khachigian LM. Vessel wall apoptosis and atherosclerotic plaque instability. J Thromb Haemost. 2005;3:465-472.
-
(2005)
J Thromb Haemost
, vol.3
, pp. 465-472
-
-
Kavurma, M.M.1
Bhindi, R.2
Lowe, H.C.3
Chesterman, C.4
Khachigian, L.M.5
-
27
-
-
38749096644
-
Galectin-3 gene inactivation reduces atherosclerotic lesions and adventitial inflammation in ApoE-deficient mice
-
Nachtigal M, Ghaffar A, Mayer EP. Galectin-3 gene inactivation reduces atherosclerotic lesions and adventitial inflammation in ApoE-deficient mice. Am J Pathol. 2008;172:247-255.
-
(2008)
Am J Pathol
, vol.172
, pp. 247-255
-
-
Nachtigal, M.1
Ghaffar, A.2
Mayer, E.P.3
-
28
-
-
35248867819
-
Anatomical differences and atherosclerosis in apolipoprotein E-deficient mice with 129/SvEv and C57BL/6 genetic backgrounds
-
Maedaa N, Johnson L, Kima S, Hagamana J, Friedman M, Reddick R. Anatomical differences and atherosclerosis in apolipoprotein E-deficient mice with 129/SvEv and C57BL/6 genetic backgrounds. Atherosclerosis. 2007;195:75-82.
-
(2007)
Atherosclerosis
, vol.195
, pp. 75-82
-
-
Maedaa, N.1
Johnson, L.2
Kima, S.3
Hagamana, J.4
Friedman, M.5
Reddick, R.6
-
29
-
-
0345734273
-
CD29 and CD7 mediate galectin-3-induced type II T-cell apoptosis
-
Fukumori T, Takenaka Y, Yoshii T, Kim HR, Hogan V, Inohara H, Kagawa S, Raz A. CD29 and CD7 mediate galectin-3-induced type II T-cell apoptosis. Cancer Res. 2003;63:8302-8311.
-
(2003)
Cancer Res
, vol.63
, pp. 8302-8311
-
-
Fukumori, T.1
Takenaka, Y.2
Yoshii, T.3
Kim, H.R.4
Hogan, V.5
Inohara, H.6
Kagawa, S.7
Raz, A.8
-
30
-
-
0035825644
-
Negative regulation of T-cell activation and autoimmunity by Mgat5 N-glycosylation
-
Demetriou M, Granovsky M, Quaggin S, Dennis JW. Negative regulation of T-cell activation and autoimmunity by Mgat5 N-glycosylation. Nature. 2001;409:733-739.
-
(2001)
Nature
, vol.409
, pp. 733-739
-
-
Demetriou, M.1
Granovsky, M.2
Quaggin, S.3
Dennis, J.W.4
-
31
-
-
0042388118
-
Critical role of galectin-3 in phagocytosis by macrophages
-
Sano H, Hsu DK, Apgar JR, Yu L, Sharma BB, Kuwabara I, Izui S, Liu FT. Critical role of galectin-3 in phagocytosis by macrophages. J Clin Invest. 2003;112:389-397.
-
(2003)
J Clin Invest
, vol.112
, pp. 389-397
-
-
Sano, H.1
Hsu, D.K.2
Apgar, J.R.3
Yu, L.4
Sharma, B.B.5
Kuwabara, I.6
Izui, S.7
Liu, F.T.8
-
32
-
-
27644537437
-
Consequences and therapeutic implications of macrophage apoptosis in atherosclerosis: The importance of lesion stage and phagocytic efficiency
-
Tabas I. Consequences and therapeutic implications of macrophage apoptosis in atherosclerosis: the importance of lesion stage and phagocytic efficiency. Arterioscler Thromb Vasc Biol. 2005;25:2255-2264.
-
(2005)
Arterioscler Thromb Vasc Biol
, vol.25
, pp. 2255-2264
-
-
Tabas, I.1
-
33
-
-
42149161735
-
Regulation of alternative macrophage activation by galectin-3
-
MacKinnon AC, Farnworth SL, Hodkinson PS, Henderson NC, Atkinson KM, Leffler H, Nilsson UJ, Haslett C, Forbes SJ, Sethi T. Regulation of alternative macrophage activation by galectin-3. J Immunol. 2008;180: 2650-2658.
-
(2008)
J Immunol
, vol.180
, pp. 2650-2658
-
-
MacKinnon, A.C.1
Farnworth, S.L.2
Hodkinson, P.S.3
Henderson, N.C.4
Atkinson, K.M.5
Leffler, H.6
Nilsson, U.J.7
Haslett, C.8
Forbes, S.J.9
Sethi, T.10
|